GLP-1 receptor agonist use and postoperative complications after body contouring surgery following massive weight loss
Journal of Plastic, Reconstructive & Aesthetic Surgery · 2026-12 · 123 · 169-175
DOI: 10.1016/j.bjps.2026.09.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Plastic, Reconstructive & Aesthetic Surgery, 2026-12. Verfasst von Nulvin Djebbara-Bozo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Breast Surgery, Aalborg University Hospital, Denmark. Electronic address: n.bozo@rn.dk. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Patients who undergo body contouring surgery after massive weight loss are routinely optimised before surgery; however, the impact of preoperative glucagon-like peptide-1 receptor agonist (GLP-1 RA) exposure on postoperative outcomes remains uncertain. METHODS: We conducted a retrospective single-centre cohort study by including 282 adults who underwent body contouring surgery following massive weight loss at the Aalborg University Hospital, Denmark, between December 2022 and December 2025. Patients were categorised based on their weight-loss modality (lifestyle intervention, bariatric surgery, or GLP-1 RA treatment). Multivariable logistic regression adjusted for age, sex, body mass index, ASA class, diabetes mellitus, and procedure type was used to evaluate the association between GLP-1 RA exposure and postoperative complications. RESULTS: Compared with lifestyle-induced weight loss, GLP-1 RA exposure was found to be independently associated with increased odds of postoperative infection (OR 3.72, 95% CI 1.52-9.07; p=0.003) and wound dehiscence requiring intervention under general anaesthesia (OR 16.71, 95% CI 1.99-139.88; p=0.009), whereas no significant associations were observed for wound dehiscence requiring local anaesthesia or postoperative bleeding. Previous bariatric surgery was not associated with increased risk of any investigated complication. CONCLUSION: Despite standardised preoperative optimisation, preoperative GLP-1 RA exposure continued to be independently associated with postoperative infection and wound dehiscence requiring intervention under general anaesthesia. These findings indicate that conventional preoperative assessment may not fully capture surgical risk in patients undergoing body contouring surgery after massive weight loss.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic and Breast Surgery, Aalborg University Hospital, Denmark. Electronic address: n.bozo@rn.dk.
- Department of Plastic and Breast Surgery, Aalborg University Hospital, Denmark.
- Department of Plastic and Breast Surgery, Aarhus University Hospital, Denmark.
- Department of Plastic and Breast Surgery, Aalborg University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Denmark.
Zitieren
APA
Djebbara-Bozo, N., Yilmaz, M., Saritas, S., Birk-Sørensen, L., & Krag, A. E. (2026). GLP-1 receptor agonist use and postoperative complications after body contouring surgery following massive weight loss. Journal of Plastic, Reconstructive & Aesthetic Surgery, 123, 169-175. https://doi.org/10.1016/j.bjps.2026.09.040
Vancouver
Djebbara-Bozo N, Yilmaz M, Saritas S, Birk-Sørensen L, Krag AE. GLP-1 receptor agonist use and postoperative complications after body contouring surgery following massive weight loss. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2026;123:169-175. doi:10.1016/j.bjps.2026.09.040
BibTeX
@article{DjebbaraBozo2026,
author = {Djebbara-Bozo, Nulvin and Yilmaz, Mevlüt and Saritas, Sinem and Birk-Sørensen, Lene and Krag, Andreas E},
title = {GLP-1 receptor agonist use and postoperative complications after body contouring surgery following massive weight loss},
journal = {Journal of Plastic, Reconstructive & Aesthetic Surgery},
year = {2026},
volume = {123},
pages = {169--175},
doi = {10.1016/j.bjps.2026.09.040}
}
EUVIMED